FDA
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
-
-
-
-
-
-
-
Fennec Pharmaceuticals prices $35 million share offering at $7.50
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
-
-
-
-
-
-
-
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
-
-
-
-
-
-
-
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
-
322,241 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

